Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 60,000 shares at $9.67 ($572K) on 2023-06-15, disclosed to the SEC on 2023-06-20.
Scheduled sale ($572k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.67 | 30,000 | $290K | 50.7% |
| 2 | $9.41 | 30,000 | $282K | 49.3% |
| Total | $9.54 avg | 60,000 | $572K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |